🌍·1d agoIndustry
Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045
Publisher
A
Adial Pharmaceuticals
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on adial.com
Leave the platform to read the original full article on the publisher site.
Source: Adial Pharmaceuticals
Scope: Industry
Related coverage
More related coverage
WuXi Biologics·12h ago
PatroLab™ Digital Platform
Zymeworks·1d ago
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA
Codexis·1d ago
Codexis to share RNA manufacturing advances at TIDES USA
GH Research·1d ago